Development of a composite scoring algorithm for the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

被引：0

作者：

Basch, Ethan ^{[1
]}

Becker, Claus ^{[2
]}

Rogak, Lauren J. ^{[3
]}

Schrag, Deborah ^{[4
]}

Reeve, Bryce B. ^{[5
]}

Spears, Patricia ^{[6
]}

Smith, Mary Lou ^{[7
]}

Gounder, Mrinal M. ^{[3
]}

Mahoney, Michelle R. ^{[8
]}

Schwartz, Gary K. ^{[9
]}

Bennett, Antonia V. ^{[10
]}

Mendoza, Tito R. ^{[11
]}

Cleeland, Charles S. ^{[11
]}

Sloan, Jeff A. ^{[8
]}

Abernethy, Amy P. ^{[12
]}

Bruner, Deborah Watkins ^{[13
]}

Schwab, Gisela ^{[14
]}

Atkinson, Thomas M. ^{[3
]}

Thanarajasingam, Gita ^{[15
]}

Bertagnolli, Monica M. ^{[16
]}

Dueck, Amylou C. ^{[17
]}

机构：

[1] Univ N Carolina, Mem Sloan Kettering Canc Ctr, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[2] Deciphera Pharmaceut, Waltham, MA USA

[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[4] Harvard Canc Ctr, Dana Farber Partners Canc Care, Boston, MA USA

[5] Duke Univ, Durham, NC USA

[6] Univ N Carolina, Lineberger Comprehens Canc Ctr, Durham, NC USA

[7] Res Advocacy Network, Plano, TX USA

[8] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA

[9] Columbia Univ, New York, NY USA

[10] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA

[11] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[12] US FDA, Silver Spring, MD USA

[13] Emory Univ Hosp, Winship Canc Inst, 1364 Clifton Rd NE, Atlanta, GA 30322 USA

[14] Exelixis Inc, San Francisco, CA USA

[15] Mayo Clin, Div Hematol, Rochester, MN USA

[16] Brigham & Womens Hosp, Alliance Protocol Operat Off, 75 Francis St, Boston, MA 02115 USA

[17] Mayo Clin, Alliance Stat & Data Ctr, Scottsdale, AZ USA

来源：

QUALITY OF LIFE RESEARCH | 2019年 / 28卷

关键词：

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

208.3

引用

页码：S43 / S44

页数：2

共 50 条

[31] Validation of the German Patient- Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™)
Hagelstein, V.
Ortland, I.
Wilmer, A.
Mitchell, S. A.
Jaehde, U.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 6 - +
[32] Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Kristin M. Schroeder
Tyler Rizzieri
Ryan R. Lion
Norbert Mtenga
Mwitasrobert Gisiri
Molly McFatrich
Bryce B. Reeve
Journal of Patient-Reported Outcomes, 7
[33] Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) (vol 1, pg 1051, 2015)
Dueck, A. C.
Mendoza, T. R.
Mitchell, S. A.
JAMA ONCOLOGY, 2016, 2 (01) : 146 - 146
[34] Impact of recall period on the accuracy of selected items from the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Mendoza, Tito R.
Bennett, Antonia V.
Mitchell, Sandra A.
Reeve, Bryce B.
Atkinson, Thomas M.
Li, Yuelin
Rogak, Lauren
Dueck, Amylou C.
Basch, Ethan
QUALITY OF LIFE RESEARCH, 2014, 23 : 141 - 142
[35] Swahili translation and cultural adaptation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Schroeder, Kristin M.
Rizzieri, Tyler
Lion, Ryan R.
Mtenga, Norbert
Gisiri, Mwitasrobert
McFatrich, Molly
Reeve, Bryce B.
JOURNAL OF PATIENT-REPORTED OUTCOMES, 2023, 7 (01)
[36] Refinement of the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) via cognitive interviewing.
Hay, J.
Atkinson, T. M.
Mendoza, T. R.
Reeve, B. B.
Willis, G.
Gagne, J. J.
Abernethy, A. P.
Cleeland, C. S.
Schrag, D.
Basch, E. M.
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[37] Methodological standards for using the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in cancer clinical trials Comment
Basch, Ethan
Thanarajasingam, Gita
Dueck, Amylou C.
CLINICAL TRIALS, 2022, 19 (03) : 274 - 276
[38] Routine Surveillance of Chemotherapy Toxicities in Cancer Patients Using the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Wang, Tian Qi
Samuel, Joseph N.
Brown, M. Catherine
Vennettilli, Ashlee
Solomon, Hannah
Eng, Lawson
Liang, Mindy
Gill, Gursharan
Merali, Zahra
Tian, Chenchen
Cheng, Nicholas Y. H.
Campbell, Matthew
Patel, Devalben
Liu, Ai Xin
Liu, Geoffrey
Howell, Doris
ONCOLOGY AND THERAPY, 2018, 6 (02) : 189 - 201
[39] Acceptability of the NCI patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in women with metastatic breast cancer (MBC)
Nichols, Christine
Mitchell, Sandra A.
Lang, Kathy
Federico, Victoria
Castro, Kathleen M.
Rogak, Lauren J.
Lalla, Deepa
Clauser, Steven B.
Reeve, Bryce B.
Denicoff, Andrea
Chen, Alice P.
Piekarz, Richard
Atkinson, Thomas Michael
Mayer, Musa
Brammer, Melissa G.
Sit, Laura
O'Mara, Ann M.
Minasian, Lori M.
Basch, Ethan M.
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
[40] Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Liu, Lei
Suo, Tingting
Shen, Yongqing
Geng, Cuizhi
Song, Zhengchuan
Liu, Fengxia
Wang, Jianxin
Xie, Yanli
Zhang, Yanshou
Tang, Tiantian
Zhang, Lina
Wang, Weina
QUALITY OF LIFE RESEARCH, 2020, 29 (11) : 3009 - 3015

← 1 2 3 4 5 →